Form 4 Tracker
Jonathan Zalevsky

Chief R&D Officer · 7 filings · Latest: Aug 18, 2026

NEKTAR THERAPEUTICS
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
NKTR
Jonathan ZalevskyChief R&D OfficerAug 18, 2026
Sale
$71.98186$13.4K9,570
NKTR
Zalevsky Jonathan—Aug 18, 2026
Proposed Sale
$71.98186$13.4K—
NKTR
Jonathan ZalevskyChief R&D OfficerJun 30, 2026
Sale
$70.005,681$397.7K9,756
NKTR
JONATHAN ZALEVSKY—Jun 30, 2026
Proposed Sale
$65.395,681$371.5K—
NKTR
Jonathan ZalevskyChief R&D OfficerJun 15, 2026
Sale
$60.715,538$336.2K15,437
NKTR
JONATHAN ZALEVSKY—Jun 15, 2026
Proposed Sale
$59.385,538$328.8K—
NKTR
Jonathan ZalevskyChief R&D OfficerMay 19, 2026
Sale
$65.51199$13.0K20,975
NKTR
Zalevsky Jonathan—May 19, 2026
Proposed Sale
$65.51199$13.0K—
NKTR
Jonathan ZalevskyChief R&D OfficerFeb 18, 2026
Sale
$73.00180$13.1K21,174
NKTR
Zalevsky Jonathan—Feb 18, 2026
Proposed Sale
$73.00180$13.1K—
NKTR
Jonathan ZalevskyChief R&D OfficerJan 20, 2026
Sale
$35.673,867$137.9K21,354
NKTR
Zalevsky Jonathan—Jan 20, 2026
Proposed Sale
$35.673,867$137.9K—
NKTR
Zalevsky Jonathan—Nov 25, 2025
Proposed Sale
$58.821,157$68.1K—
NKTR
Zalevsky Jonathan—Sep 4, 2025
Proposed Sale
$33.521,721$57.7K—
NKTR
Zalevsky Jonathan—Sep 2, 2025
Proposed Sale
$30.10485$14.6K—
NKTR
Zalevsky Jonathan—Aug 19, 2025
Proposed Sale
$26.59725$19.3K—
NKTR
Zalevsky Jonathan—May 19, 2025
Proposed Sale
$0.671310,712$7.2K—
NKTR
Zalevsky Jonathan—Feb 19, 2025
Proposed Sale
$1.0110,300$10.4K—
NKTR
Zalevsky Jonathan—Dec 19, 2024
Proposed Sale
$0.940351,115$48.1K—
NKTR
Zalevsky Jonathan—Nov 19, 2024
Proposed Sale
$1.017,785$7.9K—